Related Experiment Video
Updated: May 20, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets
O A Kent1, K Fox-Talbot, M K Halushka
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. kent@lunenfeld.ca
Abstract:
A lack of expression of miR-143 and miR-145 has been demonstrated to be a frequent feature of colorectal tumors. Activating KRAS mutations have been reported in 30-60% of colorectal cancers and an inverse correlation between Kras and miR-143/145 expression has been observed. Previously, we have demonstrated that oncogenic Kras leads to repression of the miR-143/145 cluster in pancreatic cancer and is dependent on the Ras responsive element (RRE) binding protein (RREB1), which negatively regulates miR-143/145 expression. In the present study, we have found that RREB1 is overexpressed in colorectal adenocarcinoma tumors and cell lines, and the expression of the miR-143/145 primary transcript is inversely related to RREB1 expression. In colorectal cancer cell lines, the miR-143/145 cluster is repressed by RREB1 downstream of constitutively active KRAS. RREB1 is activated by the MAPK pathway and negatively represses the miR-143/145 promoter through interaction with two RREs. In addition, overexpression of miR-143 or miR-145 in HCT116 cells abrogates signaling through the MAPK, PI3K and JNK pathways by downregulation of both KRAS and RREB1 in addition to downregulation of a cohort of genes in the MAPK signaling cascade. These results establish a complex network of regulation through which the miR-143/145 cluster is able to modulate KRAS signaling in colorectal cancer.
Insights
MicroRNAs miR-143 and miR-145 are underexpressed in colorectal cancer. The Ras responsive element binding protein 1 (RREB1) represses these microRNAs, offering a new therapeutic target for KRAS-driven colorectal tumors.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- miR-143 and miR-145 are frequently downregulated in colorectal tumors.
- Activating KRAS mutations are common in colorectal cancer, with an observed inverse correlation to miR-143/145 expression.
- Oncogenic KRAS was previously shown to repress miR-143/145 in pancreatic cancer via RREB1.
Purpose of the Study:
- To investigate the role of RREB1 in the repression of miR-143/145 in colorectal cancer.
- To elucidate the regulatory network involving KRAS, RREB1, and miR-143/145 in colorectal adenocarcinoma.
- To explore the therapeutic potential of miR-143/145 in modulating signaling pathways in colorectal cancer.
Main Methods:
- Assessed RREB1 and miR-143/145 expression in colorectal tumors and cell lines.
- Investigated the regulatory relationship between RREB1, KRAS, and miR-143/145 using colorectal cancer cell lines.
- Utilized reporter assays to confirm RREB1's interaction with the miR-143/145 promoter.
- Overexpressed miR-143 or miR-145 in HCT116 cells to analyze downstream signaling pathway modulation.
Main Results:
- RREB1 is overexpressed in colorectal adenocarcinoma, inversely correlating with miR-143/145 primary transcript expression.
- RREB1, activated by the MAPK pathway, represses the miR-143/145 promoter in colorectal cancer cell lines downstream of active KRAS.
- Overexpression of miR-143/145 abrogated MAPK, PI3K, and JNK signaling by downregulating KRAS, RREB1, and other MAPK pathway genes.
Conclusions:
- RREB1 acts as a key repressor of the miR-143/145 cluster in KRAS-driven colorectal cancer.
- A complex regulatory network exists where miR-143/145 modulates KRAS signaling.
- These findings highlight the miR-143/145 cluster as a potential therapeutic target in colorectal cancer treatment.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
MAPK Signaling Cascades
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway
MicroRNAs
MicroRNAs
